Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07064109

Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients

Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in Acute Coronary Syndromes Patients

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
380 (estimated)
Sponsor
Shanghai Tongji Hospital, Tongji University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of this prospective cohort study was to investigate the multi-omics characteristics of the efficacy of colchicine treatment in patients with ACS and to construct a model of efficacy. The main questions the study aims to answer are \- Specific mechanisms of colchicine therapy in patients with ACS; Mechanism-based modelling to identify the population that benefits from colchicine treatment.

Conditions

Interventions

TypeNameDescription
DRUGColchicine 0.5 MG Oral Tablet Once DailyColchicine 0.5 MG Oral Tablet Once Daily

Timeline

Start date
2025-07-01
Primary completion
2027-07-01
Completion
2027-07-01
First posted
2025-07-14
Last updated
2025-09-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07064109. Inclusion in this directory is not an endorsement.

Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients (NCT07064109) · Clinical Trials Directory